8.225
price up icon1.59%   0.1285
 
loading
Daxor Corporation stock is traded at $8.225, with a volume of 1,014. It is up +1.59% in the last 24 hours and up +9.23% over the past month. Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$8.0965
Open:
$8.0793
24h Volume:
1,014
Relative Volume:
0.17
Market Cap:
$40.56M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
27.39
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+6.27%
1M Performance:
+9.23%
6M Performance:
-11.56%
1Y Performance:
-6.11%
1-Day Range:
Value
$8.0793
$8.38
1-Week Range:
Value
$7.73
$8.38
52-Week Range:
Value
$6.55
$10.00

Daxor Corporation Stock (DXR) Company Profile

Name
Name
Daxor Corporation
Name
Phone
212-330-8500
Name
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Name
Employee
0
Name
Twitter
@DaxorBVA
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
DXR's Discussions on Twitter

Compare DXR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Instruments & Supplies icon
DXR
Daxor Corporation
8.38 40.11M 2.61M 1.69M 0 0.3003
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
553.61 197.20B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
168.59 50.02B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
85.31 42.88B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
243.75 36.10B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
BAX
Baxter International Inc
29.39 15.84B 11.89B -560.00M 191.00M -1.10

Daxor Corporation Stock (DXR) Upgrades & Downgrades

Date Action Analyst Rating Change
May-16-19 Initiated Ascendiant Capital Markets Buy

Daxor Corporation Stock (DXR) Latest News

pulisher
May 27, 2025

(DXR) Proactive Strategies - news.stocktradersdaily.com

May 27, 2025
pulisher
May 17, 2025

(DXR) Investment Analysis - news.stocktradersdaily.com

May 17, 2025
pulisher
May 14, 2025

Daxor announces new findings from Duke University on BVA - TipRanks

May 14, 2025
pulisher
May 14, 2025

Daxor (DXR) Highlights Key Heart Failure Study Results | DXR Sto - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Daxor Announces Duke University Study on Blood Volume - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Duke Research Reveals 40% of Heart Failure Patients Misdiagnosed with Anemia, Study Shows - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Daxor (DXR) Expands Diagnostic Solutions Across U.S. Healthcare Systems | DXR Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems - GlobeNewswire

May 13, 2025
pulisher
May 07, 2025

Daxor announces opening of new BVA program at Florida center - TipRanks

May 07, 2025
pulisher
May 07, 2025

Daxor (DXR) Launches Advanced BVA Program in Tampa Bay Healthcare Center | DXR Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Has $214,000 Stock Holdings in Daxor Co. (NASDAQ:DXR) - Defense World

May 07, 2025
pulisher
May 07, 2025

Daxor announces expansion of BVA capabilities in three new hospitals - TipRanks

May 07, 2025
pulisher
May 06, 2025

Daxor (DXR) Expands Blood Volume Analysis with New Hospital Part - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Daxor (DXR) Expands Blood Volume Analysis with New Hospital Partnerships | DXR Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance - GlobeNewswire

May 06, 2025
pulisher
May 05, 2025

NeuroMetrix (NASDAQ:NURO) and Daxor (NASDAQ:DXR) Head-To-Head Comparison - Defense World

May 05, 2025
pulisher
May 02, 2025

Daxor Corporation Secures Funding for Blood Volume Analyzer Study - Medical Product Outsourcing

May 02, 2025
pulisher
Apr 28, 2025

Daxor stock hits 52-week low at $6.83 amid market challenges - MSN

Apr 28, 2025
pulisher
Apr 24, 2025

Critical Analysis: Daxor (NASDAQ:DXR) versus Integra LifeSciences (NASDAQ:IART) - The AM Reporter

Apr 24, 2025
pulisher
Apr 22, 2025

Daxor Corporation to Exhibit at the 45th International Society for Heart and Lung Transplant (ISHLT) Annual Meeting and Scientific Sessions - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Daxor Corporation to Exhibit at the 45th International - GlobeNewswire

Apr 22, 2025
pulisher
Apr 22, 2025

Revolutionary Blood Volume Analysis: How Daxor's 98% Accurate Tech is Transforming Heart and Lung Care - Stock Titan

Apr 22, 2025
pulisher
Apr 22, 2025

Daxor (NASDAQ:DXR) versus Integra LifeSciences (NASDAQ:IART) Head to Head Review - Defense World

Apr 22, 2025
pulisher
Apr 21, 2025

(DXR) Trading Report - news.stocktradersdaily.com

Apr 21, 2025
pulisher
Apr 18, 2025

Daxor Corporation to Showcase Innovative Blood Volume - GlobeNewswire

Apr 18, 2025
pulisher
Apr 17, 2025

Daxor (DXR) to Exhibit at MedAxiom CV Transforum Spring'25 Conference | DXR Stock News - GuruFocus

Apr 17, 2025
pulisher
Apr 17, 2025

Daxor to showcase blood volume analysis at Cardiovascular Transforum conference - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

Revolutionary Blood Volume Technology Slashes Mortality Rates by 82%Groundbreaking Clinical Results Unveiled - Stock Titan

Apr 17, 2025
pulisher
Apr 15, 2025

Daxor announces new data at ACC on blood volume analysis - TipRanks

Apr 15, 2025
pulisher
Apr 15, 2025

Daxor (DXR) Unveils Promising Heart Failure Study Results at ACC Conference | DXR Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

New Research at ACC25 Shows Daxor BVA-Identified Euvolemic - GlobeNewswire

Apr 15, 2025
pulisher
Apr 15, 2025

Breakthrough Heart Failure Study: Daxor BVA Test Doubles Patient Survival Rates - Stock Titan

Apr 15, 2025
pulisher
Apr 11, 2025

Daxor (DXR) Submits Next-Gen Blood Analyzer to FDA for Approval - GuruFocus

Apr 11, 2025
pulisher
Apr 10, 2025

Daxor submits new blood volume analyzer to FDA By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer - marketscreener.com

Apr 10, 2025
pulisher
Apr 10, 2025

Daxor submits new blood volume analyzer to FDA - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer - GlobeNewswire

Apr 10, 2025
pulisher
Apr 10, 2025

Revolutionary Blood Volume Analyzer With Military Backing Advances Toward FDA Green Light - Stock Titan

Apr 10, 2025
pulisher
Apr 07, 2025

CEO’s Bold Move: Major Investment in Daxor Stock - TipRanks

Apr 07, 2025
pulisher
Apr 07, 2025

Daxor CEO Michael Feldschuh purchases over $16,000 in stock By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

Daxor CEO Michael Feldschuh purchases over $16,000 in stock - Investing.com Australia

Apr 07, 2025
pulisher
Apr 07, 2025

DAXOR CEO Michael Richard Feldschuh Buys 2,063 Shares - TradingView

Apr 07, 2025
pulisher
Apr 05, 2025

Where are the Opportunities in (DXR) - news.stocktradersdaily.com

Apr 05, 2025
pulisher
Apr 04, 2025

Daxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call Transcript - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Daxor (NYSEAMERICAN:DXR) Stock Passes Above 200-Day Moving Average – Here’s Why - Defense World

Apr 04, 2025
pulisher
Apr 02, 2025

Daxor announces new data from Duke University on BVA at ACC - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Daxor’s BVA technology gains traction at cardiology event - Investing.com

Apr 02, 2025
pulisher
Apr 02, 2025

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo - GlobeNewswire

Apr 02, 2025
pulisher
Apr 02, 2025

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Duke Research Reveals Why Daxor's Blood Test Outperforms Traditional Heart Failure Methods - Stock Titan

Apr 02, 2025

Daxor Corporation Stock (DXR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$72.78
price down icon 0.47%
$178.62
price down icon 1.52%
medical_instruments_supplies COO
$68.16
price down icon 0.00%
$61.60
price down icon 0.90%
medical_instruments_supplies WST
$209.51
price down icon 0.56%
medical_instruments_supplies BAX
$29.44
price down icon 3.77%
Cap:     |  Volume (24h):